Alto Neuroscience

Ceretype Neuromedicine

This company develops functional MRI and AI-powered biomarker platforms for pharmaceutical developers and clinicians to measure brain circuitry in psychiatric and neurological diseases.

Neumora Therapeutics

This biopharmaceutical company develops medicines for patients with neuropsychiatric disorders and neurodegenerative diseases.

Exin Therapeutics

This company develops an artificial intelligence platform to discover and design neurotherapeutics targeting neural circuits for patients with neurological and neuropsychiatric disorders.

Mindstate Design Labs

This biotechnology company develops custom psychedelic therapeutics using an artificial intelligence platform to treat mental health conditions for patients with various psychiatric disorders.

Neumora Therapeutics (NASDAQ: NMRA)

This biopharmaceutical company develops precision medicines for patients with neuropsychiatric disorders and neurodegenerative diseases through a data-driven neuroscience platform.

Sensorium Therapeutics

This biotech company develops central nervous system therapies for patients with anxiety, epilepsy and neurodegenerative diseases using a machine learning drug discovery platform.

BioXcel

This biopharmaceutical firm develops artificial intelligence-driven medicines for neuroscience and immuno-oncology patients, including approved treatments for agitation in psychiatric conditions.

ATAI

This biopharmaceutical company develops psychedelic-based treatments and mental health medicines for patients with neurological and psychiatric disorders, such as treatment-resistant depression and anxiety.